Lupin is releasing Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, which are the generic of Boehringer Ingelheim’s Atrovent Nasal Spray, 0.03% and 0.06%. Ipratropium Bromide Nasal ...
Ipratropium bromide 0.06% (42mcg/spray); aqueous soln. <5yrs: not recommended. 5–11yrs: 2 sprays in each nostril 3 times daily. ≥12yrs: 2 sprays in each nostril 3–4 times daily. Epistaxis, dry mouth ...
Pharma major Lupin Ltd on Friday said it has launched Ipratropium Bromide nasal spray, used in treatment of runny nose, in the US market. The Ipratropium Bromide nasal solution (nasal spray) launched ...
Global pharma major Lupin Limited (Lupin) announced the launch of ipratropium bromide nasal solution (nasal spray), 0.03% and 0.06%, in the United States. Ipratropium bromide nasal solution (nasal ...
Lupin receives FDA nod for generic Atrovent Ipratropium bromide nasal solution 0.06% is indicated for symptomatic relief of rhinorrhea associated with the common cold or seasonal allergic rhinitis for ...
Q: I read your article about the man who always gets a runny nose when he eats. I, too, suffered from this problem for many years. I finally saw an ear, nose and throat specialist who prescribed ...
To earn CME related to this news article, click here. January 16, 2009 — The US Food and Drug Administration (FDA) has approved revisions to the safety labeling to advise of the potential for ...
Lupin gets USFDA nod for Ipratropium Bromide Nasal Solution(0.03%) under abbreviated new drug application(ANDA). The approved drug is a generic of Atrovent Nasal ...
Review the side-effects of Ipratropium Bromide as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In ...
As I mentioned last week, a miserable cold is striking lots of my patients, spreading grief across the land. The typical symptoms are nasal congestion, cough and the mother of all malaise. Since there ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results